
6th work meeting
Lake Biel, Switzerland
The patient-role meeting: what patients actually need, how industry could become a trusted partner rather than a cost, and the state of the art in cell-based therapy.
- Dates
- 8–11 September
- Venue
- Lake Biel, Switzerland
- Convened by
- Dr. Marco Traub
Programme
What was discussed
- 01
European Innovation Partnership on Active and Healthy Ageing
- 02
Involvement and identification of specific aims towards patients' role
- 03
Stem cell and drug safety, and epigenetic profiling
Specific topics
- What are the patient-orientated needs, with a focus on quality of life and satisfaction?
- How could the role of the pharmaceutical industry change from drug producer and target for juridical trials to a respected patient partner?
- What significant measures are important to improve communication between patients, health policy, industry and regulators beyond the marketing level?
- How could patients be better informed with the implementation of IT technology?
- What are the measures to track down changes in patients' satisfaction?
- How to generate efficiently the paradigm change from weighting clinical indicators such as surrogate response and endpoints for quality of life towards individualised and regenerative medicine, with bench-to-bed approaches in integrated scenarios?
- What is the potential of stem cell technology concerning drug safety?
- What is the state-of-the-art status of cell-based therapies in clinical practice?
- Does regenerative medicine offer the solution for “long live living” in dignity?
Dr. Mary Baker, MBE — in her words
“The sad thing is that pharma companies are not involved in the major health systems; they're peripheral. They should not be seen as a cost, they should be seen as a trusted partner.”
Speakers
Who spoke
Dr. Mary Baker, MBE
Management Board of the European Medicines Agency (EMEA); Chair of the Working Group on Parkinson's Disease
Thomas Bols
Vice President, Corporate Affairs EU, Biogen International GmbH, Switzerland
Marco Cappato
Segretario dell'Associazione Luca Coscioni; Member of the City Council of Milan, Italy
Prof. Tomas J. Ekström
Department of Clinical Neuroscience, Karolinska Institutet, Sweden
Prof. Miomir Knezevic
National Institute of Biology, University of Ljubljana, Slovenia
Dr. Jeya Prakash
Age Management Consultant, Harley Street, London
Dr. Thomas Syburra
Senior Consultant Cardiac Surgeon, Lucerne Kantonsspital, Switzerland; Major, Swiss Air Force
Prof. Ralf Tönjes
Paul-Ehrlich-Institut, Division of Medical Biotechnology, Germany; Goethe University, Frankfurt am Main
Dr. Marco Traub
Project Coordinator and CEO, TESCT, Berne and London




